United Kingdom Agricultural Microbial Market to Reach USD 599 Million by 2032, Growing at a CAGR of 8.4% During 2026–2032

The agricultural microbial market in the United Kingdom was valued at USD 311 million in 2025 and is projected to reach USD 369 million in 2026. The market is expected to expand at a CAGR of 8.4% during 2026–2032, reaching USD 599 million by 2032. This growth reflects strengthening government support, expanding organic farmland, and rising private-sector investment in sustainable agricultural innovation across the UK.

Furthermore, Defra reported a 9.1% rise in UK wheat area to 1.7 million hectares in 2025, alongside 8.5% growth in potato production to 7.1 million tonnes, expanding demand for microbial seed treatments and biofungicides. Moreover, the UK Government’s target to reduce potential pesticide pressure on the environment by 10% by 2030 is accelerating adoption of biopesticides and biofertilizers as effective alternatives to chemical crop protection products.

In parallel, the market reflects rising uptake of stress-tolerance biostimulants, driven by the hottest and driest UK spring since at least 1893 in 2025. Consequently, investment is flowing into stabilized formulation technologies addressing microbial viability loss during storage, with UK BioSolutions companies raising USD 344.37 million in equity financing during 2025, of which the agriculture and food segment accounted for 52%.

By microbial type, Bacteria dominate with approximately 48% share, supported by continuous product innovation from companies such as Azotic Technologies and Bionema Group. As a result, Liquid formulations lead by delivery format with approximately 44% share. The market remains moderately fragmented, with the Top 5 players—BASF SE, Syngenta Group, Bayer AG, Novonesis, and Corteva Agriscience—collectively accounting for approximately 45% share, as stated in the recent report “UK Agriculture Microbial Market Analysis, 2026”.

United Kingdom Agricultural Microbial Market Highlights

The agricultural microbial market in the United Kingdom was valued at USD 311 million in 2025 and is projected to reach USD 369 million in 2026. The market is expected to expand at a CAGR of 8.4% during 2026–2032, reaching USD 599 million by 2032.
By microbial type, Bacteria dominate the market with approximately 48% share, led by widespread adoption of Bacillus thuringiensis and Gluconacetobacter diazotrophicus.
By formulation type, Liquid formulations account for approximately 44% share, supported by compatibility with existing spray and fertigation systems.
The market is moderately fragmented, with the Top 5 companies collectively accounting for approximately 45% share.